Siemens Healthineers launches brain health research portfolio with first biomarker assays now available
Siemens Healthineers announced today its offerings for brain health research are expanding, with the brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for 1. Every year, there are nearly 10 million new cases of dementia diagnosed worldwide2. Alzheimer’s disease is the most common, contributing to … Read more